期刊文献+

HIV阳性宫颈癌与HIV阴性宫颈癌的对照分析 被引量:4

Comparative analysis on HIV- positive cervical cancer and HIV- negative cervical cancer
原文传递
导出
摘要 目的:探讨HIV感染相关性宫颈癌的发病率和一般临床特点。方法:收集2008年4月-2012年3月间住院治疗的全部HIV阳性宫颈癌患者(A组)的临床资料,同时收集2010年3月间连续入院同等数量HIV阴性宫颈癌患者(B组)的临床资料,将两组资料进行对比。结果:两组患者在发病年龄(P=0.038)、T淋巴细胞亚群构成(P=0.000)及全身多发淋巴结肿大发生率(P=0.003)方面均有统计学差异。结论:HIV阳性宫颈癌患者较HIV阴性患者发病更早、T淋巴细胞免疫功能下降、全身多发淋巴结肿大发生率显著增加,提示HIV感染导致免疫功能低下,在HIV阳性宫颈癌发生过程中发挥了重要作用。 Objective: To explore the incidence rate and general clinical characteristics of human immunodeficiency virus( HIV)infection- related cervical cancer. Methods: The clinical data of patients with HIV infection- related cervical cancer( group A) treated in the hospital from April 2008 to March 2012 were collected; meanwhile,the clinical data of patients with HIV- negative cervical cancer( group B) treated in the hospital in March 2010 were collected,then the data in the two groups were compared. Results: There were statistically significant differences in onset age( P = 0. 038),proportion of T lymphocyte subsets( P = 0. 000) and incidence rate of total body multiple lymphadenectasis( P = 0. 003) between the two groups. Conclusion: The patients with HIV infection- related cervical cancer is younger than the patients with HIV- negative cervical cancer,the immunologic function of T lymphocytes decreases,the incidence rate of total body multiple lymphadenectasis increases significantly,which indicate that HIV infection can induce impaired immunity and play an important role in occurrence of HIV infection- related cervical cancer.
出处 《中国妇幼保健》 CAS 北大核心 2014年第16期2554-2556,共3页 Maternal and Child Health Care of China
关键词 HIV 感染 宫颈癌 T淋巴细胞亚群 HIV Infection Cervical cancer T lymphocyte subset
  • 相关文献

参考文献10

  • 1Fujita Y,Otsuki H,Watanabe Y,et al.Generation of a rep-lication-competent chimeric simian-human immunodeficien-cy virus carrying env from subtype C clinical isolate through in-tracellular homologous recombination [ J ].Virology,2013,436(1):100-111.
  • 2Ruiz A,Sehmitt K,Culley N,et al.Simian-human immu-nodeficiency viruses expressing chimeric subtype B/C Vpu pro-teins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4(+)T cell loss in macaques [J].Virology,2013,435(2):395-405.
  • 3邵树军,吕毅,孙萍,董晓峰,郝宝岚,任磊.肿瘤患者感染HIV抗体阳性分析与研究[J].中华医院感染学杂志,2008,18(2):204-205. 被引量:3
  • 4Shiels MS,Pfeiffer RM,sarcoma,selected non Hall HI,et al.Proportions of Kaposi Hodgkin lymphomas,and cervical cancer in the United States occurring in persons with AIDS,1980-2007 [J].JAMA,2011,305(14):1450-1459.
  • 5吴立春,宋晓玉,张珂,张海宇.肿瘤医院就诊患者HIV感染状况分析[J].实用肿瘤杂志,2012,27(5):502-505. 被引量:5
  • 6王红羚,张天勇.肿瘤患者HIV 74例感染情况分析[J].重庆医学,2012,41(31):3302-3304. 被引量:6
  • 7何方平,王星,张跃新,张朝霞,林仁勇,卢晓梅,何斌,温浩.新疆地区487例肿瘤患者HIV血清流行病学调查分析[J].新疆医科大学学报,2007,30(2):105-107. 被引量:4
  • 8Firnhaber C,Wilkin T.Human papillomavirus vaccines:where do they fit in HIV-infected individuals? [ J ].Curr HIV/AIDS Rep,2012,9(3):278-286.
  • 9Zhang YX,Gui XE,Zhong YH,et al.Cancer in cohort of HIV-infected population:prevalence and clinical character-istics [J].J Cancer Res Clin Oncol,2011,137(4):609-614.
  • 10冯瑞芳,刘中夫.HIV感染者/AIDS病人死亡原因的研究进展[J].中国艾滋病性病,2013,19(3):229-230. 被引量:36

二级参考文献72

共引文献46

同被引文献72

  • 1彭雪,胡丽娜.HPV感染及危险因素的研究[J].实用妇产科杂志,2010,26(3):168-170. 被引量:37
  • 2Ruiz A, Schmitt K, Culley N, et al. Simian - human immunodeficiency viruses expressing chimeric subtype B/C Vpu proteins demonstrate the importance of the amino terminal and transmembrane domains in the rate of CD4 (+) T cell loss in macaques. Virology, 2013, 435: 395-405.
  • 3Averbach SH, Gravitt PE, Nowak RG, et al. The association between cervical human papillomavims infection and HIV acquisition among women in Zimbabwe. AIDS, 2010, 24: 1035-1042.
  • 4Couture MC, Page K, Stein ES, et al. cervical human papillomavirus infection among young women engaged in sex work in PhnomPenh, Cambodia: prevalence, genotypes, risk factors and association with HIV infection. BMC Infect Dis , 2012, 12: 166.
  • 5Denny LA, Franceschi S, de Sanjose S, et al. Human papillomavirus, human immunosuppression. Vaccine, 2012, 30 (Suppl 5): F168-F174.
  • 6Firnhaber C, Wilkin T. Human papillomavirus vaccines: where do they fit in HIV-infected individuals. Curr HIV/AIDS Rep, 2012, 9: 278-286.
  • 7Zhang YX, Gui XE, ZhongYH, et al. Cancerincoboft of HIV infected population: prevalence and clinical characteristics. J Cancer Res Clin OncoI, 2011, 137: 609-614.
  • 8Ma Y, Madupu R, Karaoz U, et al. Human papillomavirus community in healthy persons, defined by metagenomics analysis of human microbiome project shotgun sequencing data sets [ J ]. J Virol ,2014,88 (9) :4786-4797.
  • 9Smith MA, Tellier PP, Roger M, et al. Determinants of human pap- illomavirus coinfections among montreal university students: the influence of behavioral and bialogic factors[ J]. Cancer Epidemiol Biomarkers Prey, 2014,23 ( 5 ) : 812 -822.
  • 10Chen M, Jen I, Chen YH, et al. Cancer incidence in a Nationwide HIV/AIDS patient cohort in Taiwan in 1998-2009 [ J]. J Acquir Immune Defic Syndr,2014,65 (4) :463-472.

引证文献4

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部